Asia-Pacific Market Growth Potential Offset by Domestic Regulations And Cultural Attitudes in Dental Biologics Markets

Share Article

According to a recent report by iData Research, the Asia-Pacific dental bone graft substitute market is set to demonstrate double-digit annual growth, surpassing $300 million by 2021.

Domestic regulations on medical devices in the Asia-Pacific region have largely limited growth.

According to a recent report by iData Research (http://www.idataresearch.com), the majority of the Asia-Pacific dental bone graft substitute (DBGS) and barrier membrane markets are set to grow significantly. China is expected to demonstrate the highest levels of growth, while Japan will exhibit the lowest. The significant surge of dental implant procedure numbers is set to generate major market value growth. The rise of the implant market in all four countries is set to continue to fuel growth for the DBGS and dental barrier membrane markets in the overall region.

“Domestic regulations on medical devices in the Asia-Pacific region have largely limited growth. However, growing consumer awareness, and research and development efforts are driving the market,” explains Dr. Kamran Zamanian, CEO of iData. “Acceptance and availability of xenograft and allograft materials are expected to further fuel market growth.”

The South Korean market for DBGS and barrier membranes is the most highly developed relative to the other countries in the Asia-Pacific region. As a result of the high market penetration of both dental implants and related regenerative/biomaterial products, growth is expected to be relatively modest in comparison to other Asia-Pacific countries.

The Australian market is more moderately developed as a result of consumer awareness levels and a higher GDP per capita. Approvals of allograft materials and the recently established subsidiary by Geistlich are set to generate DBGS and dental barrier membrane market growth in Australia.

Leading Competitors
Geistlich is the clear market leader of the DBGS and barrier membrane markets in the Asia-Pacific region with a market share of almost 50% due to its presence in all four countries. Geistlich is the only company that possesses licensed approval for the distribution of its products in all four of the regions in Asia-Pacific.

Domestic market leaders vary greatly from country to country due to varying regulations in each country.

Other notable competitors in the Asia-Pacific markets for dental bone graft substitutes and barrier membranes include Genoss, Olympus Terumo Biomaterials, HOYA Techsurgical, Hans Biomed, Shanxi OsteoRad, Zimmer Dental, among others.

For Further Information
More on the DBGS market in the Asia-Pacific region can be found in the report series published by iData entitled Asia-Pacific Markets for Dental Bone Graft Substitutes and Barrier Membranes. This report covers Japan, South Korea, Australia, and China, and includes market segment for allografts, xenografts, synthetics, resorbable barrier membranes, and non-resobable barrier membranes.

The full iData series on the market for DBGS and barrier membranes covers the U.S., Brazil, Argentina, Mexico, China, Japan, South Korea, Australia, India, and 15 countries in Europe. Full reports provide a comprehensive analysis including units sold, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.

Register online or email us at info(at)idataresearch(dot)net for an Asia-Pacific Markets for Dental Bone Graft Substitutes and Barrier Membranes report brochure and synopsis.

About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by country, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.

About iData Research
iData Research (http://www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology and more.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Marvin Cidamon
iData Research
+1 (604) 266-6933 Ext: 205
Email >

Marvin Cidamon
iData Research
604-266-6933 205
Email >
@iDataResearch
Follow >
iData Research
Like >
iData Research

Follow us on
Visit website